Clinical Observation on Integrative Medicine for 30 Cases of Refractory Epistaxis

BAI Shangjie; CUI Chunlian; JIN Xianghua

doi:10.13288/j.11-2166/r.2014.17.013

您当前的位置：

首页 >

文章列表页 >

Clinical Observation on Integrative Medicine for 30 Cases of Refractory Epistaxis

更新时间：2021-11-17

- Clinical Observation on Integrative Medicine for 30 Cases of Refractory Epistaxis
- Journal of Traditional Chinese Medicine Vol. 55, Issue 17, Pages: 1487-1490(2014)
- 作者机构：
  
  延边大学附属医院
- 作者简介：
- 基金信息：
- DOI：10.13288/j.11-2166/r.2014.17.013
  CLC： R765.23
- Published：2014
- 稿件说明：
移动端阅览
[1]白尚杰,崔春莲,金香花.中西医结合治疗顽固性鼻出血30例临床观察[J].中医杂志,2014,55(17):1487-1490.

BAI Shangjie, CUI Chunlian, JIN Xianghua. Clinical Observation on Integrative Medicine for 30 Cases of Refractory Epistaxis[J]. Journal of Traditional Chinese Medicine2014, 55(17): 1487-1490.
[1]白尚杰,崔春莲,金香花.中西医结合治疗顽固性鼻出血30例临床观察[J].中医杂志,2014,55(17):1487-1490. DOI： 10.13288/j.11-2166/r.2014.17.013.

BAI Shangjie, CUI Chunlian, JIN Xianghua. Clinical Observation on Integrative Medicine for 30 Cases of Refractory Epistaxis[J]. Journal of Traditional Chinese Medicine2014, 55(17): 1487-1490. DOI： 10.13288/j.11-2166/r.2014.17.013.

摘要

目的观察中西医结合治疗顽固性鼻出血的临床疗效。方法 90例顽固性鼻出血患者随机分为鼻内镜组、阿莫西林组、一清胶囊组

每组30例。鼻内镜组使用鼻内镜微波治疗;阿莫西林组在鼻内镜微波治疗后服用阿莫西林胶囊

每次0.5g

每天3次

连服3

天;一清胶囊组在阿莫西林组治疗基础上再服用一清胶囊

每次1g

每日3次

连服2周。对患者治疗前后尿激酶型纤溶酶原激活物（uPA）及其受体（uPAR）、凝血酶原时间（PT）、活化部分凝血活酶时间（APTT）、凝血酶时间（TT）及血浆纤维蛋白原水平（FIB）进行检测。同时观察临床疗效、治愈次数。结果一清胶囊组临床疗效总有效率90.0%

显著高于鼻内镜组的63.3%（P

0.05）

与阿莫西林组的80.0%比较

差异无统计学意义（P

0.05）。一清胶囊组一次治愈率显著高于鼻内镜组与阿莫西林组（P

0.05）。治疗前后鼻内镜组uPA、PT、FIB

阿莫西林组uPA、PT、APTT、FIB

一清胶囊组uPA、uPAR、PT、APTT、TT及FIB比较差异均有统计学意义（P

0.05）;治疗后一清胶囊组uPA、uPAR、APTT、TT、FIB与鼻内镜组及阿莫西林组

PT与鼻内镜组比较差异均有统计学意义（P

0.05）。结论中西医结合治疗顽固性鼻出血可提高临床疗效

改善凝血指标。

Abstract

Objective To observe the efficacy of integrative medicine for refractory epistaxis. Methods Ninety cases of refractory epistaxis were randomized into the nasal endoscopy group

amoxicillin group and Yiqing Capsules group

with 30 in each. The nasal endoscopy group was given nasal endoscopy microwave treatment. The amoxicillin group was given 0. 5 g of amoxicillin three times daily for 3 to 5 days on the basis of nasal endoscopy group. The Yiqing Capsules group was given 1 g of Yiqing Capsules three times daily for 2 weeks on the basis of amoxicillin group.The levels of urokinase plasminogen activator（ uPA）

uPA receptor（ uPAR）

prothrombin time（ PT）

activated partial thromboplastin time（ APTT）

thrombin time（ TT） and FIBrinogen（ FIB） were detected before and after treatment. The efficacy and cure rate were observed. Results The total effective rate of Yiqing Capsules group and nasal endoscopy group was 90. 0% and 63. 3% respectively

with a significant difference between groups（ P < 0. 05）.The total effective rate of amoxicillin group was 80. 0%

with no significant difference comparing with Yiqing Capsules group（ P > 0. 05）. The one-time cure rate in the Yiqing Capsules group was significantly higher than that in the nasal endoscopy group and amoxicillin group（ P < 0. 05）. After treatment

the levels of uPA

PT and FIB were significantly improved in the nasal endoscopy group

the levels of uPA

APTT and FIB were significantly improved in the amoxicillin group and the levels of uPA

uPAR

APTT

TT and FIB were significantly improved in the Yiqing Capsules group（ P < 0. 05）. Comparing with the nasal endoscopy group and amoxicillin group

the levels of uPA

uPAR

APTT

TT and FIB were significantly improved in the Yiqing Capsules group after treatment（ P < 0. 05）.Comparing with the nasal endoscopy group

the PT level in the Yiqing Capsules group was significantly improved（ P <0. 05）. Conclusion Integrative medicine is effective for refractory epistaxis. It can improve clinical outcomes and coagulation.

关键词

Keywords

references

查看原文

Views

138

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Meta-Analysis of Integrative Therapy for Small Cell Lung Cancer

Clinical Observation on Integrative Medical Pathway for 100 Cases of Gastric Cancer

Clinical Observation on Integrative Medicine for 60 Cases of Acute Exacerbation of Chronic Pulmonary Heart Disease Complicated by Gastrointestinal Symptoms

The Philosophy and Practical Pathway of "Dao （道）-Shen （神）-Formula" in Traditional Chinese Medicine

Current Status and Strategic Recommendations for Randomized Controlled Trials on Functional Dyspepsia-Irritable Bowel Syndrome Comorbidity：from a Real-World Research Perspective

Related Author

TIAN Xin1

ZHOU Faxiang2

WANG Weigang1

JIA Liqun1

TIAN Yongli

XIA Ningjun

LI Xuan

LIU Shenlin

Related Institution

Japan Friendship Hospital

Henan University of Chinese Medicine

The Affiliated Hospital of Nanjing University of Chinese Medicine

The Affiliated Hospital of Chengdu University of TCM

The Affiliated Hospital of North Sichuan Medical College

Address：No.16, Nanxiao street, Dongzhimen, Dongcheng District, Beijing Postal code：100700
Tel：010-64035632 Email：jtcmcn@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备09064830号-19 京公网安备11010102007558号
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰